Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 3.43 0.29% 0.01
ORMP closed up 0.29 percent on Wednesday, January 16, 2019, on 2.69 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Earnings due: Jan 17

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical ORMP trend table...

Date Alert Name Type % Chg
Jan 16 Shooting Star Candlestick Bearish 0.00%
Jan 16 Crossed Above 20 DMA Bullish 0.00%
Jan 16 Pocket Pivot Bullish Swing Setup 0.00%
Jan 16 Doji - Bearish? Reversal 0.00%
Jan 15 20 DMA Resistance Bearish 0.29%
Jan 15 Outside Day Range Expansion 0.29%
Jan 14 20 DMA Resistance Bearish 1.78%
Jan 14 Narrow Range Bar Range Contraction 1.78%
Jan 14 NR7 Range Contraction 1.78%
Jan 14 Wide Bands Range Expansion 1.78%

Older signals for ORMP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Is ORMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.98
52 Week Low 2.97
Average Volume 31,668
200-Day Moving Average 5.4181
50-Day Moving Average 3.8383
20-Day Moving Average 3.4095
10-Day Moving Average 3.443
Average True Range 0.1907
ADX 17.47
+DI 22.4695
-DI 22.0387
Chandelier Exit (Long, 3 ATRs ) 3.4879
Chandelier Exit (Short, 3 ATRs ) 3.5421
Upper Bollinger Band 3.8579
Lower Bollinger Band 2.9611
Percent B (%b) 0.52
BandWidth 26.302977
MACD Line -0.1232
MACD Signal Line -0.1581
MACD Histogram 0.0349
Fundamentals Value
Market Cap 45.69 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.61
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.91
Resistance 3 (R3) 3.93 3.79 3.83
Resistance 2 (R2) 3.79 3.67 3.78 3.80
Resistance 1 (R1) 3.61 3.59 3.70 3.59 3.78
Pivot Point 3.47 3.47 3.52 3.46 3.47
Support 1 (S1) 3.29 3.35 3.38 3.27 3.08
Support 2 (S2) 3.15 3.27 3.14 3.06
Support 3 (S3) 2.97 3.15 3.03
Support 4 (S4) 2.95